Filtered By:
Specialty: Neurology
Condition: Epilepsy
This page shows you your search results in order of date. This is page number 6.
Order by Relevance | Date
Total 1226 results found since Jan 2013.
Ischaemic or transient attack? Magnetic resonance imaging in transient ischaemic attack: a review of 106 cases
CONCLUSIONS: The early use of MRI in the clinical suspicion of TIA makes it possible to gather evidence of CRIS and optimises the diagnostic and therapeutic approach for patients.PMID:36440745 | DOI:10.33588/rn.7511.2022232
Source: Revista de Neurologia - November 28, 2022 Category: Neurology Authors: A C Novo P A Pinz ón-Benavides P Rozas-Fern ández M Mart ínez-Palicio A Garc ía-Rúa C Ant ón-González I Casado-Men éndez R Su árez-Moro M T Temprano-Fern ández Source Type: research
Clinical Features and Risk Factors of Mortality in Patients with Posterior Reversible Encephalopathy Syndrome
CONCLUSIONS: Our results indicate that PRES could be considered as a sign of a very high-risk patient. We also demonstrated that heart failure and stroke were independent risk factors for death in patients with PRES; moreover, pregnancy was a protective factor.PMID:36419591 | PMC:PMC9678458 | DOI:10.1155/2022/9401661
Source: Behavioural Neurology - November 24, 2022 Category: Neurology Authors: Hong-Wei Cui Ru-Yi Lei Bo-Ai Zhang Source Type: research
Thromboembolic Risks with Concurrent Direct Oral Anticoagulants and Antiseizure Medications: A Population-Based Analysis
ConclusionsAlthough CYP/P-gp-modulating antiseizure medications were associated with an increased risk of ischemic stroke when paired with DOAC in the primary analysis, such a phenomenon was not found among patients with epilepsy who took phenytoin, valproate, or levetiracetam with DOAC. Therefore, these antiseizure medication options among patients with epilepsy with concurrent DOAC should not be restricted solely based on their potential drug –drug interactions. Yet, the increased mortality during concurrent use of DOAC with phenytoin or valproate might call for caution.
Source: CNS Drugs - November 24, 2022 Category: Neurology Source Type: research
Neuroprotective Potency of Safranal Against Neurological Disorders
Curr Mol Med. 2022 Nov 17. doi: 10.2174/1566524023666221117104612. Online ahead of print.ABSTRACTA great number of research has been focused on plants as a source of medicine against many diseases to overcome the many side effects of chemical drugs. Safranal, one of the main constituents of saffron [Crocus sativus], has a broad spectrum of pharmacological effects, including anti-inflammatory, antioxidant, and antiapoptotic effects. The present review elaborates on the current understanding of the neuroprotective effects of safranal. According to data published so far, safranal has the potential to exert neuroprotective eff...
Source: Epilepsy Curr - November 18, 2022 Category: Neurology Authors: Elham Fazeli Mohammad Hossein Eshaghi Ghalibaf Fatemeh Forouzanfar Source Type: research
Preventive Approaches in Women's Neurology: Prepartum, Pregnancy, and Postpartum
Semin Neurol DOI: 10.1055/a-1958-0633Women's neurology is the subspecialty within neurology concerned with the distinct healthcare needs of women. In this article, we review current literature and expert management strategies regarding disease-specific neurologic concerns of women, with an emphasis on issues related to contraception, pregnancy, and lactation. Health conditions that we discuss in this article include epilepsy, headache, stroke, multiple sclerosis, and Chiari I malformation. Current findings on neurologic disease in women suggest that many women with neurologic disease can safely manage their disease during ...
Source: Seminars in Neurology - November 17, 2022 Category: Neurology Authors: Kirkpatrick, Laura Waters, Janet O'Neal, Mary Angela Tags: Review Article Source Type: research
Epilepsy Surgery in Adult Stroke Survivors with New-Onset Drug-Resistant Epilepsy
CONCLUSIONS: Patients with stroke-related drug-resistant epilepsy are infrequently considered for epilepsy surgery that could reduce morbidity and mortality.PMID:36373342 | DOI:10.1017/cjn.2022.300
Source: The Canadian Journal of Neurological Sciences - November 14, 2022 Category: Neurology Authors: Tresah C Antaya Britney N Le Lucie Richard Amna Qureshi Salimah Z Shariff Luciano A Sposato Jorge G Burneo Source Type: research
